Lymphoblastic lymphoma of the pre-b phenotype with cutaneous presentation

Dermatology

Volumn 195, Issue 3, 1997, Pages 289-292

  Schmitt, I M ^a   Manente, L ^a   Di Matteo, A ^a   Felici, F ^b   Giangiacomi, M ^c   Chimenti, S ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Division of Hematology Oncology   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Common acute lymphatic leukemia antigen; Lymphoblastic lymphoma; Pre B cell lymphoma; Skin neoplasm

Indexed keywords

ANTINEOPLASTIC AGENT; PARAFFIN;

ARM; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPHOBLASTOMA; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN LYMPHOMA; TUMOR CELL;

EID: 0030856267     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000245966     Document Type: Article

References (21)

1. Harris NL. Jaffe ES. Stein A. Banks PM. Chan JK, Cleary ML, Delsol G. et al: A revised European-America classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994:84: 1361-1392.
2. Burg G. Braun-Falco O: Cutaneous Lymphoma. Pseudolymphomas and Related Disorders. Berlin. Springer, 1983. pp 296-303.
3. Vaillant L. Lorette G. Colombat P. Sorbier C: Primary cutaneous lymphoblastic lymphoma of non-B. non-T phenotype. Arch Dermatol 1990;126:400-401.
4. Weiss LM, Bindl JM. Picozzi VJ. Link MP. Warnike RA: Lymphoblastic lymphoma: An i mmunophenotype study of 26 cases with comparison to T-cell acute lymphoblastic leukemia. Blood 1986;67:474-478.
5. Swcdlow SH, Habeshaw JA. Ruehards MA, Rainey M. Murray LY. Stansfeld AG: T lymphoblastic lymphoma with Leu 7 positive phenotype and unusual clinical course: A multiparameter study. Leuk Res 1985;9:167-173.
6. Chimenti S. Lombardo M: Malattie linfoprolif-eralive cutanee e sistemiche. Genova. SIOMS. 1991. vol 262.
7. Sheibani K, Nathwani BN. Winberg CD: Anti-genically defined subgroups of lymphoblastic lymphoma: Relationship to clinical presentation and biological behaviour. Cancer 1987; 60:183-190.
8. Link MP. Roper M. Dorfmann RF. Crist WM. Cooper MD, Levy R: Cutaneous lymphoblastic lymphoma with pre-B markers. Blood 1983;61:838-841.
9. Meyers L. Hakami N: Pre-B cell cutaneous lymphoma in infancy: A unique clinical entity. Med Pcdiatr Oncol 1984; 12:252-254.
10. Sanders CA. Medeiros LJ. Abruzzo LV. Horak ID, Jaffe ES: Lymphoblastic lymphoma presenting in cutaneous sites: A clinicopathologic analysis of six cases. J Am Acad Dermatol 1991;25:1023-1031.
11. Picozzi VJ. Coleman CN: Lymphoblastic lymphoma. Semin Oncol 1990:17:96-103.
12. Chessels J, Hardisty R, Rapson N: Acute lymphoblastic leukemia in children: Classification and prognosis. Lancet 1997; Vol ii: 1307-1309.
13. Medeiros IJ, Picker LJ, Abel EA. Hu CH, Hoppe RT. Warnke RA. Wood GS: Cutaneous lymphoid hyperplasia: Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma. J Am Acad Dermatol 1989:21:929-942.
14. Bollum FJ: Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 1979;54:1203-1215.
15. Ritz J. Nadler LM, Bahn AK. McConarty JN. Pesando JM. Schlossmann SF: Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood 1981:58:648-652.
16. National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphoma: Summary and description of an only formulation for clinical usage: The non-Hodgkin’s lymphoma pathologic classification project. Cancer 1982:49:2112-2135.
17. Cheng AL. Su IJ. Tien HF. Wang CC. Chen YC. Wang CH: Characteristic clinicopathologic features of adult B-ccll lymphoblastic lymphoma with special emphasis on differential diagnosis with an atypical form probably of blastic lymphocytic lymphoma of intermediate differentiation origin. Cancer 1994;73: 706-710.
18. Anderson JR. Wilson JF. Jenkin DT, Meadows AT. Kersey J. Chilcote RR, Coccia P et al.: Childhood non-Hodgkin’s lymphoma: Results of a randomized therapeutic trial comparing a 4 drug regimen (COMP) to a 10 drug regimen (LSA.L,). N Engl J Med 1983:308:559-565.
19. Cossmann J, Chused TM. Fisher RL, Magrath I. Bollmu F. Jaffe ES: Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 1983:43:4486-4490.
20. Nakamura N. Tominaga K. Abe M. Wakasa H: A case of lymphoblastic lymphoma with pre-B cell phenotype (letter). Acta Haematol 1991; 86:53-54.
21. Bernard A. Murphy SB. Melvin S. Bowmann WP, Caillaud J. Lemerle J, Boumscll L: Non-T. non-B lymphomas are rare in childhood and associated with cutaneous tumor. Blood 1982; 59:549-554.